We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Latest Industry Insights

The Importance of Automated Solutions for Laboratory Experiments   content piece image
Industry Insight

The Importance of Automated Solutions for Laboratory Experiments

Technology Networks recently spoke with Jean-François Bellec, ProteinSimple applications scientist, to learn about Bio-Techne’s history and how its solutions enable researchers to work efficiently and ensure accuracy in their experiments. In this interview, Jean-François also highlights how the company’s offerings have supported researchers throughout the COVID-19 pandemic.
ABP-300: A Neutralizing Antibody Treatment for COVID-19 content piece image
Industry Insight

ABP-300: A Neutralizing Antibody Treatment for COVID-19

Technology Networks recently had the pleasure of speaking with Abpro’s CEO, Ian Chan, to learn more about the company’s research and development pipeline. Chan discusses in detail the development of ABP-300, a monoclonal antibody that neutralizes SARS-CoV-2 by associating with the virus’s spike protein.
Advancing Research of Inflammatory Intestinal Diseases  content piece image
Industry Insight

Advancing Research of Inflammatory Intestinal Diseases

We spoke to Dr Lorna Ewart, Emulate’s executive vice president of science, to learn more about the limitations of traditional inflammatory intestinal disease models, what makes the Colon Intestine-Chip a more relevant model and how it can be used to investigate potential drug targets.
Harnessing T Cells To Detect Disease  content piece image
Industry Insight

Harnessing T Cells To Detect Disease

In this interview, Dr Sudeb Dalai, senior medical director at Adaptive Biotechnologies, discusses the role that T-cell analysis may play in the diagnosis and treatment of diseases including SARS-CoV-2.
Simplifying Component Selection in Lateral Flow Assay Development content piece image
Industry Insight

Lateral Flow Assay Development

Here we summarize the webinar that was hosted by Klaus Hochleitner, PhD., which provides an overview of the important factors and considerations for robust lateral flow assay development.
Minipig Study Tests Gene Therapy for Huntington's Disease content piece image
Industry Insight

Minipig Study Tests Gene Therapy for Huntington's Disease

A new body of work published in Science Translational Medicine outlines the preclinical testing of a microRNA-based gene therapy for Huntington's disease – AMT-130 – in minipigs.
Bioprocessing and Bioproduction Trends in Cell and Gene Therapies content piece image
Industry Insight

Bioprocessing and Bioproduction Trends in Cell and Gene Therapies

In this interview, Technology Networks spoke with Neal Goodwin, PhD, Chief Scientific Officer at Teknova, to learn more about current bioprocessing and bioproduction trends in the cell and gene therapy space. Goodwin also discusses the impact of the COVID-19 pandemic on the biopharmaceutical sector and highlights how the industry has united to contribute to the development of vaccines at this critical time.
Ingestible Technologies for Diagnosis of Gastrointestinal Disorders content piece image
Industry Insight

Ingestible Technologies for Diagnosis of Gastrointestinal Disorders

Progenity’s Christopher Wahl provides his insights into the research and work being done specifically with Progenity’s novel ingestible lab-in-a-capsule, PIL Dx.
Using Rapid Antigen Tests To Fight SARS-CoV-2 content piece image
Industry Insight

Using Rapid Antigen Tests To Fight SARS-CoV-2

Technology Networks recently interviewed Anthony V. Lemmo, to learn how rapid antigen tests work, how they compare to PCR tests and how they can be used to help slow the spread of SARS-CoV-2.
COVID-19: Therapeutics, Preventives and Industry Perspectives content piece image
Industry Insight

COVID-19: Therapeutics, Preventives and Industry Perspectives

Technology Networks had the pleasure of speaking with Ki-Sung Kwon, head of the R&D unit at Celltrion to learn more about therapeutic versus preventive strategies against COVID-19 and the company's monoclonal antibody-based therapeutic – CT-P59 – that is currently being developed against COVID-19.
Advertisement